Basic Information
| LncRNA/CircRNA Name | AC009014.3 |
| Synonyms | AC009014.3, LOC389332, NR_024418 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | RNA-seq, qPCR etc. |
| Sample | prostate cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | The 43 differentially expressed (DE) lncRNAs between aggressive and indolent prostate cancers included 12 annotated and 32 novel lncRNAs. The top six DE lncRNAs were selected based on large, consistent fold-changes in the RNA-Seq results. |
| Pubmed ID | 29723810 |
| Year | 2018 |
| Title | Long Noncoding RNAs AC009014.4 and Newly Discovered XPLAID Differentiate Aggressive and Indolent Prostate Cancers. |
External Links
| Links for AC009014.3 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |